Page 1 | Search Results | Hematology, ASH Education Program

1-20 of 62

Sort by

Sort Order Select

Journal Articles

Is there a role for low-dose DOACs as prophylaxis?

Alexander T. Cohen, Beverley J. Hunt

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 187–193.

https://doi.org/10.1182/hematology.2019000026

Published: 2019

Journal Articles

Managing the competing risks of thrombosis, bleeding, and anticoagulation in patients with malignancy

Hanny Al-Samkari, Jean M. Connors

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 71–79.

https://doi.org/10.1182/hematology.2019000369

Published: 2019

Journal Articles

An introduction to point-of-care testing in extracorporeal circulation and LVADs

Rachel Sara Bercovitz

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 516–521.

https://doi.org/10.1182/asheducation-2018.1.516

Published: 2018

Journal Articles

Elite athletes and anticoagulant therapy: an intermittent dosing strategy

Stephan Moll, Joshua N. Berkowitz, Christopher W. Miars

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 412–417.

https://doi.org/10.1182/asheducation-2018.1.412

Published: 2018

Journal Articles

Drug-associated thrombocytopenia

Tamam Bakchoul, Irene Marini

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 576–583.

https://doi.org/10.1182/asheducation-2018.1.576

Published: 2018

Journal Articles

Role of the anticoagulant monitoring service in 2018: beyond warfarin

Nathan P. Clark

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 348–352.

https://doi.org/10.1182/asheducation-2018.1.348

Published: 2018

Journal Articles

Who should get long-term anticoagulant therapy for venous thromboembolism and with what?

Marc Alan Rodger, Gregoire Le Gal

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 426–431.

https://doi.org/10.1182/asheducation-2018.1.426

Published: 2018

Journal Articles

Breadth of complications of long-term oral anticoagulant care

Walter Ageno, Marco Donadini

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 432–438.

https://doi.org/10.1182/asheducation-2018.1.432

Published: 2018

Journal Articles

Anticoagulating patients with high-risk acquired thrombophilias

Leslie Skeith

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 439–449.

https://doi.org/10.1182/asheducation-2018.1.439

Published: 2018

Journal Articles

Optimizing quality care for the oral vitamin K antagonists (VKAs)

Vittorio Pengo, Gentian Denas

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 332–338.

https://doi.org/10.1182/asheducation-2018.1.332

Published: 2018

Journal Articles

Should we diagnose and treat distal deep vein thrombosis?

Helia Robert-Ebadi, Marc Righini

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 231–236.

https://doi.org/10.1182/asheducation-2017.1.231

Published: 2017

Journal Articles

Symptomatic subsegmental pulmonary embolism: to treat or not to treat?

Marc Carrier, Fredrikus A. Klok

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 237–241.

https://doi.org/10.1182/asheducation-2017.1.237

Published: 2017

Journal Articles

Safety profiles of novel agent therapies in CLL

Inhye E. Ahn, Matthew S. Davids

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 354–357.

https://doi.org/10.1182/asheducation-2017.1.354

Published: 2017

Journal Articles

Incidental venous thromboembolism: is anticoagulation indicated?

Marcello Di Nisio, Marc Carrier

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 121–127.

https://doi.org/10.1182/asheducation-2017.1.121

Published: 2017

Journal Articles

HITs and misses in 100 years of heparin

Lawrence Rice

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 667–673.

https://doi.org/10.1182/asheducation-2017.1.667

Published: 2017

Journal Articles

When can we stop anticoagulation in patients with cancer-associated thrombosis?

Agnes Y. Y. Lee

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 128–135.

https://doi.org/10.1182/asheducation-2017.1.128

Published: 2017

Journal Articles

Anticoagulation with VADs and ECMO: walking the tightrope

Leslie Raffini

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 674–680.

https://doi.org/10.1182/asheducation-2017.1.674

Published: 2017

Journal Articles

Thrombectomy and thrombolysis for the prevention and treatment of postthrombotic syndrome

Suresh Vedantham

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 681–685.

https://doi.org/10.1182/asheducation-2017.1.681

Published: 2017

Journal Articles

Thrombosis and anticoagulation in the setting of renal or liver disease

Christine Ribic, Mark Crowther

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 188–195.

https://doi.org/10.1182/asheducation-2016.1.188

Published: 2016

Journal Articles

Heavy menstrual bleeding: work-up and management

Andra H. James

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 236–242.

https://doi.org/10.1182/asheducation-2016.1.236

Published: 2016

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Is there a role for low-dose DOACs as prophylaxis?

Managing the competing risks of thrombosis, bleeding, and anticoagulation in patients with malignancy

An introduction to point-of-care testing in extracorporeal circulation and LVADs

Elite athletes and anticoagulant therapy: an intermittent dosing strategy

Drug-associated thrombocytopenia

Role of the anticoagulant monitoring service in 2018: beyond warfarin

Who should get long-term anticoagulant therapy for venous thromboembolism and with what?

Breadth of complications of long-term oral anticoagulant care

Anticoagulating patients with high-risk acquired thrombophilias

Optimizing quality care for the oral vitamin K antagonists (VKAs)

Should we diagnose and treat distal deep vein thrombosis?

Symptomatic subsegmental pulmonary embolism: to treat or not to treat?

Safety profiles of novel agent therapies in CLL

Incidental venous thromboembolism: is anticoagulation indicated?

HITs and misses in 100 years of heparin

When can we stop anticoagulation in patients with cancer-associated thrombosis?

Anticoagulation with VADs and ECMO: walking the tightrope

Thrombectomy and thrombolysis for the prevention and treatment of postthrombotic syndrome

Thrombosis and anticoagulation in the setting of renal or liver disease

Heavy menstrual bleeding: work-up and management

ASH Publications

American Society of Hematology